Exact Sciences shares plunged Wednesday after the maker of Cologuard reported widening losses and cut its outlook.

Exact Sciences may have had disappointing Q3 earnings, but its liquidity cushions and new product approval indicate strong ...

Exact Sciences' Q3 report led to a ~25% drop in share price, due to a slight guidance cut and narrow revenue miss. Learn more ...

Piper Sandler analyst David Westenberg lowered the firm’s price target on Exact Sciences (EXAS) to $75 from $85 following quarterly ...

Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its third-quarter 2024 investor ...

Exact Sciences Corp ( (EXAS) ) has released its Q3 earnings. Here is a breakdown of the information Exact Sciences Corp presented to its ...

Exact Sciences stock collapsed Wednesday after the Cologuard maker reported light third-quarter sales and cut its full-year ...

Yale physicist Eduardo H. da Silva Neto led an experiment that supports the existence of a new type of superconductor.

Neurologist Richard Restak has revealed the age he believes people should stop drinking beer - as well as the reasons why.

But although Roman roads are characteristically straight, archaeologists have struggled to find evidence confirming the ...

Harvard Kennedy School Professor Jennifer Lerner, a decision scientist who studies emotion, and Vaughan Rees, the director ...